ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
65 hedge funds and large institutions have $176M invested in ChemoCentryx, Inc. in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 5 closing their positions.
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
29% more capital invested
Capital invested by funds: $136M → $176M (+$39.9M)
14% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 21
8% more funds holding
Funds holding: 60 → 65 (+5)
8% more call options, than puts
Call options by funds: $185K | Put options by funds: $172K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$9.74M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.86M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$7.24M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$2.05M |
| 5 |
VAM
Visium Asset Management
New York
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$5.21M |
| 2 |
RA
Royce & Associates
New York
|
-$1.47M |
| 3 |
Renaissance Technologies
New York
|
-$1.31M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$885K |
| 5 |
Two Sigma Investments
New York
|
-$445K |
CCXI Hedge Fund Activity: Q1 2014 in Review
65 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2014, worth a combined $176M — up 29% from $136M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CCXI positions and 5 closed out — a net gain of 5 holders — while 24 added to existing stakes and 21 trimmed.
The largest buyer was Westfield Capital Management, opening a new position worth an estimated $9.74M. The largest seller was Great Point Partners, cutting an estimated $5.21M.
- 65 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2014, up from 60 in Q4 2013.
- Funds reported $176M of ChemoCentryx, Inc. stock for Q1 2014, up 29% quarter-over-quarter.
- 10 funds opened new ChemoCentryx, Inc. positions in Q1 2014 and 5 closed out, a net change of +5 holders.
- The largest ChemoCentryx, Inc. buyer in Q1 2014 was Westfield Capital Management, an estimated $9.74M added.
- The largest ChemoCentryx, Inc. seller in Q1 2014 was Great Point Partners, an estimated $5.21M sold.
Based on aggregated 13F filings for Q1 2014.